1. Home
  2. Companies
  3. LGP
  4. Material Events

Little Green Pharma (ASX:LGP) — Material Events

ASX:LGP · 18 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 4 articles Significant 10 articles Notable 3 articles Routine 1 article Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
10
US Executive Order Sparks Major Shift in Global Medicinal Cannabis MarketHigh
US Executive Order to Reschedule Cannabis Boosts Global Medicinal Cannabis Outlook
22 Dec 2025 ·ASX Announcement ·Unexpected ·85
Little Green Pharma Surpasses $10M Revenue Mark Amid European ExpansionMedium
Little Green Pharma Q1 FY26 revenue tops $10M with strong European growth and regulatory progress
30 Oct 2025 ·Quarterly Activities Report and Appendix 4C ·85
Little Green Pharma and Cannatrek Set to Forge Medicinal Cannabis PowerhouseHigh
Little Green Pharma reports record revenue and announces pivotal merger with Cannatrek
30 Jan 2026 ·Quarterly Activities Report and Appendix 4C ·85
Cannatrek Shareholders Approve Scheme for Acquisition by Little Green PharmaMedium
Cannatrek Shareholders Approve Acquisition Scheme by Little Green Pharma
10 Apr 2026 ·Scheme Meeting Results ·85
Federal Court Greenlights Little Green Pharma's Cannatrek TakeoverMedium
Federal Court Approves Little Green Pharma's Acquisition of Cannatrek
25 May 2026 ·Scheme of Arrangement Approval ·85
Little Green Pharma Narrows Loss as European Sales Surge in HY 2025Medium
Little Green Pharma posts revenue growth and narrows loss in HY 2025, boosted by European sales
21 Nov 2025 ·Half Year Financial Report ·85
Little Green Pharma Hits Record Revenues and Nears Cannatrek Merger CompletionMedium
Little Green Pharma posts record revenues, advances Cannatrek merger, and benefits from US cannabis rescheduling
30 Apr 2026 ·Quarterly Activities Report and Appendix 4C ·85
Little Green Pharma Accelerates European Growth with Danish Expansion and German Brand LaunchMedium
Little Green Pharma posts strong Q4 FY25 growth, expands Danish capacity, and launches brand in Germany
17 July 2025 ·Quarterly Activities Report and Appendix 4C ·80
Little Green Pharma FY2026 Revenue Climbs 15% Despite $1.4M Loss on Inventory HitsMedium
Little Green Pharma FY2026 revenue rises 15% to AUD 42.5M; posts AUD 1.4M loss amid European expansion
21 May 2026 ·Annual Report ·80
Little Green Pharma Updates Cannatrek Acquisition with Revised Timetable and Facility Sale TerminationMedium
Little Green Pharma updates Cannatrek shareholders on acquisition scheme with revised timetable and terminated WA facility sale
1 Apr 2026 ·Supplementary Scheme Booklet ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.